Where is Coherus headquartered?

Coherus is located in Redwood City, CA.

Who invested in Coherus?

Coherus has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Coherus?

Coherus closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

coherus.com

Coherus

Coherus is a California-based biopharmaceutical company that develops and commercializes biosimilar therapeutics for the treatment of cancer.

Business Model:

Revenue: $239.1M

Employees: 201-500

Geographic Data

Address: 333 Twin Dolphin Drive

City: Redwood City

State: CA

Zip: 94065

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$50M

Raised Total:

$545M

Social

Facebook

Twitter

Crunchbase

Metrics

1,607,292Website Global Rank

13,144Website Monthly Traffic

Twitter Followers

Description

Coherus is a California-based biopharmaceutical company that develops and commercializes biosimilar therapeutics for the treatment of cancer.

Contact Phone:
+18007945434

Contact Email:

IPO Details

Coherus went public on 11/7/2014 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
11/7/2014

Ticker Symbol:
CHRS

IPO Price:
$14/share

Amount Raised:
$85M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
7/2013	Debt Financing	1	$28M	Helix Ventures
1/2012	Series B		$0	Medpace Daiichi Sankyo Cook Pharmica, LLC Helix Ventures Lilly Ventures Medpace Daiichi Sankyo Cook Pharmica, LLC Helix Ventures Lilly Ventures
2/2021	Post-IPO Equity	1	$50M	Shanghai Junshi Biosciences Shanghai Junshi Biosciences Shanghai Junshi Biosciences Shanghai Junshi Biosciences
5/2023	Post-IPO Equity		$50M
1/2019	Post-IPO Debt	1	$75M	HealthCare Royalty Partners HealthCare Royalty Partners HealthCare Royalty Partners HealthCare Royalty Partners
3/2011	Series A		$0	Medpace Helix Ventures Medpace Helix Ventures
1/2007	Venture Round	1	-	Sofinnova Investments Sofinnova Investments
12/2017	Post-IPO Equity		$6.8M
2/2017	Post-IPO Equity		$117.1M
9/2015	Equity		$10M
1/2022	Post-IPO Debt		$300M	Pharmakon Advisors, LP
11/2020	Post-IPO Equity	1	-	Lord Abbett Lord Abbett Lord Abbett Lord Abbett
1/2022	Post-IPO Debt	1	$100M	Pharmakon Advisors Pharmakon Advisors Pharmakon Advisors Pharmakon Advisors
5/2014	Series C	12	$54.7M	Eight Roads Ventures F-Prime Capital Helix Ventures KMG Capital Partners Kohlberg Kravis Roberts Lilly Ventures RA Capital Management Rock Springs Capital Sofinnova Investments Venrock Viva Capital Advisors Vivo Capital Kohlberg Kravis Roberts KMG Capital Partners Viva Capital Advisors Sofinnova Investments Eight Roads Ventures Rock Springs Capital Kohlberg Kravis Roberts
11/2017	Equity		$6.8M
2/2016	Post-IPO Equity		$100M
11/2014	IPO		$85M
5/2014	Series C		$55M	KKR & Co. L.P. Venrock RA Capital Management Rock Springs Capital Fidelity Biosciences Sofinnova Ventures Lilly Ventures Vivo Capital
11/2020	Post-IPO Equity	1	-	Lord Abbett Lord Abbett Lord Abbett Lord Abbett

Acquisitions

Announced Date	Name	Price
6/2023	Surface Oncology
2/2014	InteKrin

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details